It was suggested a protective role of ACE2 upregulation and ARBs/ACE inhibitors treatment in COVID-19 and raised concerns that ARBs/ACE inhibitors treatment could promote SARS- CoV-2 infection by increasing the expression of ACE2. This evidence concerns the gene ACE and COVID-19.